Allorion Therapeutics presents TYK2 inhibitor ARTS-011 for the treatment of inflammatory disease May 13, 2022
Dianthus closes series A financing to support development of antibody complement therapeutics May 4, 2022
Identification of human MAb that broadly neutralizes sarbecoviruses unveils a crucial CDRH3 motif May 3, 2022
SPK-001 demonstrates neutralization activity in vitro against SARS-CoV-2 variants of concern April 14, 2022
AAHI receives donation to support development of next-generation vaccine and therapeutic solutions April 12, 2022
RSS